Makiko Mitsunami | Medicine | Best Researcher Award

Dr. Makiko Mitsunami | Medicine | Best Researcher Award

Dr. Makiko Mitsunami, Integrated Center for Women’s Health, Japan

Dr. Makiko Mitsunami is a dedicated physician-scientist specializing in obstetrics, gynecology, and reproductive epidemiology. Born in Shiga, Japan, she obtained her MD from Jichi Medical University in 2008 and earned an MMSc from Harvard Medical School in Clinical Investigations. She later completed her PhD at Jichi Medical University, further enriching her academic prowess. Her professional journey includes rigorous clinical residency and postdoctoral research fellowships at prestigious institutions such as the Harvard T.H. Chan School of Public Health. Dr. Mitsunami’s research explores the intersection of nutrition, environmental health, and reproductive outcomes, with a strong focus on plant-based diets, infertility, and hormonal biomarkers. Her numerous grants and awards—including multiple research fundings from the Fuji Protein Foundation—underscore her impactful work. As a research associate at Harvard, she continues to mentor students and contribute to groundbreaking studies, advocating for women’s reproductive health globally through science and public health interventions.

Profile

Google Scholar

Suitability Summary for Research for Best Researcher Award

Dr. Makiko Mitsunami is an exemplary candidate for the Research for Best Researcher Award based on her robust academic background, extensive clinical and research experience, and impactful contributions to medical science, particularly in obstetrics, gynecology, and reproductive health. She holds an MD, MMSc in Clinical Investigations, and a PhD, combining rigorous clinical training with advanced research expertise from prestigious institutions such as Jichi Medical University and Harvard Medical School. This strong educational foundation supports her credibility and authority in her field.

Throughout her career, Dr. Mitsunami has balanced clinical responsibilities and academic pursuits, holding roles from junior resident to senior medical staff and research fellow. Her postdoctoral research experience at Harvard’s T.H. Chan School of Public Health highlights her commitment to advancing public health knowledge, particularly in areas such as nutrition, environmental health, and epidemiology, under the guidance of notable principal investigators. Her leadership experience as Associate Director of Obstetrics and Gynecology at Higashi-Ohmi General Medical Center further demonstrates her ability to integrate research with clinical practice and manage healthcare delivery effectively.

🎓 Education 

Dr. Makiko Mitsunami embarked on her academic journey at Jichi Medical University, where she earned her MD in 2008, followed by postgraduate residency training in obstetrics and gynecology across multiple medical centers in Japan. Pursuing a passion for clinical research, she enrolled in Harvard Medical School’s Master of Medical Sciences (MMSc) in Clinical Investigations, graduating in May 2021. She culminated her academic accomplishments with a PhD in Medicine from Jichi Medical University in 2023, reflecting a robust blend of clinical acumen and research excellence. Her academic path was enriched with prestigious international training experiences at Harvard T.H. Chan School of Public Health, where she contributed to studies on nutrition, epidemiology, and environmental health. Her cross-disciplinary education and commitment to women’s health have made her a prominent figure in reproductive medicine and global health. Her educational background empowers her ongoing contributions to cutting-edge research and healthcare improvement.

💼 Professional Experience 

Dr. Mitsunami’s professional experience spans clinical practice, academic appointments, and cutting-edge public health research. She began her career as a junior and senior resident in obstetrics and gynecology across several hospitals in Japan, including Otsu Red Cross and Shiga University of Medical Science Hospital. From 2012 to 2015, she served as a Visiting Assistant Professor of General Surgery, later becoming Associate Director of the Ob-Gyn department at Higashi-Ohmi General Medical Center. Her passion for research led her to the Harvard T.H. Chan School of Public Health, where she currently serves as a Postdoctoral Research Fellow and Research Associate under esteemed mentors such as Dr. Jorge Chavarro and Dr. Shruthi Mahalingaiah. Her research addresses nutrition, endocrine health, infertility, and environmental exposures. She has also contributed significantly to student training and curriculum development. Her diverse professional background uniquely positions her at the intersection of clinical medicine and impactful research.

🏅 Awards and Recognition

Dr. Makiko Mitsunami has been widely recognized for her contributions to reproductive medicine and clinical research. Early in her career, she received the Young Investigator’s Award in 2012 from the Society for Study of the Kidney in Pregnancy for her work on cardiomyopathy in dialysis patients. She has been awarded multiple competitive research grants from the Fuji Protein for Research Foundation between 2021 and 2025, totaling over $30,000 in support of her investigations into soy-based diets and reproductive health. In 2023, she was honored with the JMSA Scholarship from the Japanese Medical Society of America. Notably, she secured a prestigious Rotary Foundation Global Scholarship for her research on plant-based diets and hypertensive disorders during pregnancy, valued at $69,776. Additionally, she was selected as a Rose Service Learning Program Fellow at Harvard in 2024. These accolades reflect her growing global impact and academic excellence.

🌍 Research Skill On Medicine

Dr. Mitsunami brings a multifaceted research skill set to the field of reproductive medicine, grounded in clinical expertise and public health methodology. Her core research skills include epidemiologic study design, statistical data analysis, and translational research in human reproduction. She excels in linking environmental exposures and dietary patterns—especially plant-based diets—to hormonal health and fertility. Her work leverages biomarker analyses such as Anti-Müllerian Hormone (AMH) levels to evaluate ovarian reserve, endometriosis risk, and menopausal timing. Through her affiliations at Harvard T.H. Chan School of Public Health, she collaborates across departments of nutrition, epidemiology, and environmental health, contributing to multidisciplinary studies. Fluent in Japanese and English, she conducts culturally sensitive research on fertility awareness among Japanese populations in the U.S.. Her ability to secure funding, lead research protocols, and co-author impactful publications highlights her as a capable and forward-thinking researcher improving global reproductive outcomes.

📖 Publication Top Notes

  • Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence
    Authors: K Kunitoki, M Funato, M Mitsunami, T Kinoshita, MR Reich
    Journal: Vaccine
    Volume(Issue): 39 (41), Pages: 6104-6110
    Citations: 42
    Year: 2021

  • Association of gestational diabetes with subsequent long-term risk of mortality
    Authors: YX Wang, M Mitsunami, JAE Manson, AJ Gaskins, JW Rich-Edwards, …
    Journal: JAMA Internal Medicine
    Volume(Issue): 183 (11), Pages: 1204-1213
    Citations: 37
    Year: 2023

  • Women’s and men’s intake of omega-3 fatty acids and their food sources and assisted reproductive technology outcomes
    Authors: A Salas-Huetos, M Arvizu, L Mínguez-Alarcón, M Mitsunami, …
    Journal: American Journal of Obstetrics and Gynecology
    Volume(Issue): 227 (2), Pages: 246.e1-246.e11
    Citations: 32
    Year: 2022

  • Paternal adherence to healthy dietary patterns in relation to sperm parameters and outcomes of assisted reproductive technologies
    Authors: A Salas-Huetos, L Mínguez-Alarcón, M Mitsunami, M Arvizu, JB Ford, …
    Journal: Fertility and Sterility
    Volume(Issue): 117 (2), Pages: 298-312
    Citations: 23
    Year: 2022

  • Physical activity before pregnancy and the risk of hypertensive disorders of pregnancy
    Authors: M Arvizu, L Minguez-Alarcon, JJ Stuart, M Mitsunami, B Rosner, …
    Journal: American Journal of Obstetrics & Gynecology MFM
    Volume(Issue): 4 (2), Article: 100556
    Citations: 19
    Year: 2022

  • Pre-pregnancy menstrual cycle regularity and length and the risk of gestational diabetes mellitus: prospective cohort study
    Authors: YX Wang, S Wang, M Mitsunami, JAE Manson, JW Rich-Edwards, …
    Journal: Diabetologia
    Volume(Issue): 64 (11), Pages: 2415-2424
    Citations: 14
    Year: 2021

  • A dietary score representing the overall relation of men’s diet with semen quality in relation to outcomes of infertility treatment with assisted reproduction
    Authors: M Mitsunami, A Salas-Huetos, L Mínguez-Alarcón, JA Attaman, JB Ford, …
    Journal: F&S Reports
    Volume(Issue): 2 (4), Pages: 396-404
    Citations: 12
    Year: 2021

  • Prepregnancy healthy lifestyle and adverse pregnancy outcomes
    Authors: S Wang, M Mitsunami, E Ortiz-Panozo, CW Leung, JAE Manson, …
    Journal: Obstetrics & Gynecology
    DOI: 10.1097
    Citations: 11
    Year: 2022

  • Men’s dietary patterns in relation to infertility treatment outcomes among couples undergoing in vitro fertilization
    Authors: M Mitsunami, A Salas-Huetos, L Mínguez-Alarcón, JA Attaman, JB Ford, …
    Journal: Journal of Assisted Reproduction and Genetics
    Volume(Issue): 38 (9), Pages: 2307-2318
    Citations: 11
    Year: 2021

  • Women’s adherence to healthy dietary patterns and outcomes of infertility treatment
    Authors: A Salas-Huetos, M Mitsunami, S Wang, L Mínguez-Alarcón, …
    Journal: JAMA Network Open
    Volume(Issue): 6 (8), Article: e2329982
    Citations: 10
    Year: 2023

 

PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

Dr. PRAJAKTA MASURKAR | Health Professions | Best Researcher Award

👤 Dr. PRAJAKTA MASURKAR, UCB, United States

Prajakta P. Masurkar, Ph.D., MPharm, is a dynamic HEOR (Health Economics and Outcomes Research) professional specializing in evidence generation for payer-focused strategies in inflammatory and rare diseases. With over 7 years of experience in HEOR research and an additional 3 years in the pharmaceutical industry, Dr. Masurkar excels in retrospective data analysis, economic modeling, patient-reported outcomes strategies, and advanced research designs. Her expertise extends to clinical development, market access, and health technology assessments (HTAs). Currently serving as HEOR Associate Director at UCB, Atlanta, she leads impactful research initiatives, integrating US payer evidence with global strategies. A skilled communicator and strategic thinker, she has a proven ability to deliver research outcomes aligning with business development and policy objectives. Dr. Masurkar’s academic journey includes a Ph.D. in Pharmaceutical Health Outcomes and Policy, reflecting her dedication to advancing healthcare innovation and enhancing the patient experience through data-driven insights.

Professional Profile

Scopus 

Orcid

🌟  Summary of Suitability for the Award

Dr. Prajakta P. Masurkar is an exemplary candidate for the “Research for Best Researcher Award.” With a profound blend of academic accomplishments, industry experience, and research expertise, Dr. Masurkar has significantly contributed to the fields of Health Economics and Outcomes Research (HEOR), pharmacoepidemiology, and pharmacoeconomics. Her seven years of HEOR research experience and additional three years in the pharmaceutical industry showcase her depth of knowledge and versatility in tackling complex challenges related to health economics, payer strategies, and clinical evidence generation.

Dr. Masurkar’s impactful work is evident in her leadership roles, including her current position as Associate Director at UCB and her tenure at Amgen, where she spearheaded numerous research initiatives. Her contributions span diverse therapeutic areas, including dermatology, inflammation, lupus, and rare diseases.

🎓 Education

Dr. Prajakta P. Masurkar holds a Ph.D. in Pharmaceutical Health Outcomes and Policy from the University of Houston, Texas, USA (2017–2021). Her doctoral research emphasized pharmacoepidemiology and pharmacoeconomics, honing her expertise in health outcomes research. She earned her Master of Pharmacy (MPharm) in Drug Development and Regulatory Affairs from Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, India, with a focus on innovative analytical methods and regulatory frameworks. Dr. Masurkar’s academic journey began with a Bachelor of Pharmacy (BPharm) from the University of Mumbai, India, where she developed foundational knowledge in pharmaceutical sciences. Throughout her education, she maintained impressive GPAs, showcasing her academic rigor and commitment to excellence. Her multidisciplinary training equips her with the skills to navigate complex health economic evaluations, evidence generation, and global regulatory landscapes, enabling her to make meaningful contributions to the field of healthcare research and policy development.

💼  Professional Experience

Dr. Prajakta P. Masurkar’s professional journey spans over a decade of impactful roles in Health Economics and Outcomes Research (HEOR) and the pharmaceutical industry. As HEOR Associate Director at UCB, Atlanta, she leads evidence generation initiatives for dermatology, integrating global strategies with US payer requirements. At Amgen, she held senior and managerial positions, driving HEOR strategies for inflammation-related conditions, including lupus and atopic dermatitis. Her responsibilities encompassed economic modeling, real-world evidence studies, and HTA submissions. Earlier roles included a Global HEOR internship at Intuitive Surgical, where she developed cost-effectiveness analyses for robotic-assisted surgeries, and a Teaching Assistantship at the University of Houston. In India, she contributed to pharmacovigilance and regulatory affairs with leading pharmaceutical firms. Dr. Masurkar’s cross-functional collaborations, strategic leadership, and technical expertise underscore her commitment to advancing patient care and optimizing healthcare value propositions through evidence-based solutions.

🏅 Awards and Recognition

Dr. Prajakta P. Masurkar has earned recognition for her exceptional contributions to health economics and outcomes research. Her achievements include impactful presentations at esteemed conferences such as the American College of Rheumatology (ACR) Annual International Meeting, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the Academy of Managed Care Pharmacy (AMCP). Notable podium and poster presentations highlight her groundbreaking work on treatment patterns, healthcare resource utilization, and cost analyses in systemic lupus erythematosus. Her expertise in economic modeling and patient-reported outcomes strategies has been acknowledged with invitations to present globally. Additionally, her dedication to advancing health outcomes research has been celebrated with opportunities to mentor and collaborate with global experts. These recognitions reflect Dr. Masurkar’s unwavering commitment to excellence and her influential role in shaping innovative solutions for complex healthcare challenges.

🌍 Research Skills On Health Professions

Dr. Prajakta P. Masurkar possesses a diverse and advanced skill set in health economics and outcomes research. Her expertise includes economic modeling, health technology assessments (HTA), and patient-reported outcomes (PRO) strategies, tailored to improve healthcare access and optimize payer value propositions. She is adept in retrospective claims analysis, real-world evidence (RWE) studies, and systematic reviews, leveraging extensive experience with databases like MarketScan, Medicare, and EMR systems. Proficient in programming tools like R, Python, and SAS, Dr. Masurkar applies quantitative and qualitative methods to generate impactful evidence. She excels in decision-analytic modeling and cost-effectiveness analyses, enhancing decision-making for stakeholders. Her technical acumen extends to scientific writing, including Global Value Dossiers (GVD) and HTA submissions, ensuring compliance and effectiveness. With an innovative approach and a commitment to precision, Dr. Masurkar’s research skills empower her to deliver solutions addressing critical gaps in healthcare.

📖 Publication Top Notes

1. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-022-00944-z
  • Year: 2022
2. Risk of Overactive Bladder Associated With Cholinesterase Inhibitors in Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
  • Citation: Journal of the American Geriatrics Society, DOI: 10.1111/jgs.17579
  • Year: 2022
3. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
  • Authors: Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu
  • Citation: Drugs & Aging, DOI: 10.1007/s40266-021-00863-5
  • Year: 2021
4. A Naturalistic Observation Study of Medication Counseling Practices at Retail Chain Pharmacies
  • Authors: Soham D. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit Sansgiry
  • Citation: Pharmacy Practice, DOI: 10.18549/PharmPract.2020.1.1696
  • Year: 2020
5. A Need of Better Pharmacovigilance System in India
  • Authors: Prajakta P. Masurkar
  • Citation: Asian Journal of Pharmaceutical and Clinical Research, DOI: 10.22159/ajpcr.2017.v10i1.14797
  • Year: 2017